These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8548303)

  • 1. NBQX, an improved non-NMDA antagonist studied in retinal ganglion cells.
    Yu W; Miller RF
    Brain Res; 1995 Sep; 692(1-2):190-4. PubMed ID: 8548303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism by which NBQX enhances NMDA currents in retinal ganglion cells.
    Yu W; Miller RF
    Brain Res; 1996 Feb; 709(2):184-96. PubMed ID: 8833754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NBQX suppresses inhibitory glycine currents in retinal ganglion cells.
    Yu W; Miller RF
    Neuroreport; 1994 Aug; 5(13):1558-60. PubMed ID: 7529589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
    Mead AN; Stephens DN
    J Pharmacol Exp Ther; 1999 Jul; 290(1):9-15. PubMed ID: 10381753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of NMDA and non-NMDA excitatory amino acid receptors in the functional organization of primate retinal ganglion cells.
    Cohen ED; Miller RF
    Vis Neurosci; 1994; 11(2):317-32. PubMed ID: 8003456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist.
    Kohara A; Okada M; Tsutsumi R; Ohno K; Takahashi M; Shimizu-Sasamata M; Shishikura J; Inami H; Sakamoto S; Yamaguchi T
    J Pharm Pharmacol; 1998 Jul; 50(7):795-801. PubMed ID: 9720630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the contributions of NMDA and non-NMDA currents to EPSPs in retinal ganglion cells.
    Velte TJ; Yu W; Miller RF
    Vis Neurosci; 1997; 14(6):999-1014. PubMed ID: 9447684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
    Maj J; Rogóz Z; Skuza G; Jaros T
    Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
    Verdoorn TA; Kleckner NW; Dingledine R
    Mol Pharmacol; 1989 Mar; 35(3):360-8. PubMed ID: 2564633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The network-selective actions of quinoxalines on the neurocircuitry operations of the rabbit retina.
    Cohen ED; Miller RF
    Brain Res; 1999 Jun; 831(1-2):206-28. PubMed ID: 10412000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPA- and kainate-receptors differentially mediate excitatory amino acid-induced dopamine and acetylcholine release from rat striatal slices.
    Jin S
    Neuropharmacology; 1997; 36(11-12):1503-10. PubMed ID: 9517420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of glutamate receptor subtypes mediating inputs to bipolar cells and ganglion cells in the tiger salamander retina.
    Hensley SH; Yang XL; Wu SM
    J Neurophysiol; 1993 Jun; 69(6):2099-107. PubMed ID: 7688801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPA-preferring receptors mediate excitatory synaptic inputs to retinal ganglion cells.
    Lukasiewicz PD; Wilson JA; Lawrence JE
    J Neurophysiol; 1997 Jan; 77(1):57-64. PubMed ID: 9120596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury?
    Prehn JH; Lippert K; Krieglstein J
    Eur J Pharmacol; 1995 Jan; 292(2):179-89. PubMed ID: 7720791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.
    Merino M; Vizuete ML; Cano J; Machado A
    J Neurochem; 1999 Aug; 73(2):750-7. PubMed ID: 10428073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA and AMPA receptors in the dorsal nucleus of the lateral lemniscus shape binaural responses in rat inferior colliculus.
    Kelly JB; Kidd SA
    J Neurophysiol; 2000 Mar; 83(3):1403-14. PubMed ID: 10712467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution.
    Randle JC; Guet T; Cordi A; Lepagnol JM
    Eur J Pharmacol; 1992 May; 215(2-3):237-44. PubMed ID: 1382998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the actions of agonists and antagonists at non-NMDA receptors of C fibres and motoneurones of the immature rat spinal cord in vitro.
    Pook P; Brugger F; Hawkins NS; Clark KC; Watkins JC; Evans RH
    Br J Pharmacol; 1993 Jan; 108(1):179-84. PubMed ID: 8094024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light-evoked excitatory synaptic currents of X-type retinal ganglion cells.
    Cohen ED
    J Neurophysiol; 2000 Jun; 83(6):3217-29. PubMed ID: 10848542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.